Stress and interferon signaling-mediated apoptosis contributes to pleiotropic anticancer responses induced by targeting NGLY1 (read more) Background Although NGLY1 is known as a pivotal enzyme that catalyses the deglycosylation of...
Read More
Check out this powerful video about how our first NGLY1 Deficiency patient was found, and the incredible Might family (founders of NGLY1.org) who work tirelessly to help others affected by NGLY1…
Written by Marc's dad, Jordi. Marc was born with low weight and stayed in the NICU for three weeks. When he was three month old, during a routine visit to...
Read More
Reprinted from the BLOOM BLOOM is talking to parents to learn about what they do to care for their mental health. First up is Laura Meffen. Laura’s daughter Emily Kerr,...
Read More
Can you share a bit of your background? I was born and grew up in the Bay Area and then continued my education in Southern California. I knew science what...
Read More
The NGLY1 Foundation (NGLY1.org) is pleased to announce the appointment of Matthew Fox to its Board of Directors. “Matt Fox brings years of experience in finance, biotech, drug development and...
Read More
Written by Willow's mom, Anna. We noticed Willows development was delayed at three month old. We were told to prepare for at minimum three years of testing, and that we...
Read More
Recent Comments